Edwin Bremer, prof. dr.

Edwin Bremer, prof. dr.

Rijksuniversiteit Groningen

H-index: 38

Europe-Netherlands

About Edwin Bremer, prof. dr.

Edwin Bremer, prof. dr., With an exceptional h-index of 38 and a recent h-index of 25 (since 2020), a distinguished researcher at Rijksuniversiteit Groningen, specializes in the field of Cancer immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Antibody desolvation with sodium chloride and acetonitrile generates bioactive protein nanoparticles

Type i membrane proteins heterodimers and methods of use thereof

Direct Functionalization of Polysaccharide‐Based Xylan Phenyl Carbonate Nanoparticles with Tumor Cell Specific Antibodies

Pd1-41bbl fusion protein and methods of use thereof

Novel high-yield potato protease inhibitor panels block a wide array of proteases involved in viral infection and crucial tissue damage

SIRPalpha-41BBL FUSION PROTEIN AND METHODS OF USE THEREOF

VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses

Design of Vaterite Nanoparticles for Controlled Delivery of Active Immunotherapeutic Proteins

Edwin Bremer, prof. dr. Information

University

Position

University Medical Center Groningen/Dept. of Hematology

Citations(all)

3844

Citations(since 2020)

1888

Cited By

2479

hIndex(all)

38

hIndex(since 2020)

25

i10Index(all)

63

i10Index(since 2020)

51

Email

University Profile Page

Rijksuniversiteit Groningen

Google Scholar

View Google Scholar Profile

Edwin Bremer, prof. dr. Skills & Research Interests

Cancer immunotherapy

Top articles of Edwin Bremer, prof. dr.

Title

Journal

Author(s)

Publication Date

Antibody desolvation with sodium chloride and acetonitrile generates bioactive protein nanoparticles

Plos one

Levi Collin Nelemans

Vinicio Alejandro Melo

Matej Buzgo

Edwin Bremer

Aiva Simaite

2024/3/14

Type i membrane proteins heterodimers and methods of use thereof

2024/3/7

Direct Functionalization of Polysaccharide‐Based Xylan Phenyl Carbonate Nanoparticles with Tumor Cell Specific Antibodies

ChemBioChem

Vrouyr Bilemjian

Yusheng Lin

Wei Wan

Gabriella Egri

Gerwin Huls

...

2024/1/18

Pd1-41bbl fusion protein and methods of use thereof

2024/1/11

Novel high-yield potato protease inhibitor panels block a wide array of proteases involved in viral infection and crucial tissue damage

Journal of Molecular Medicine

Nienke Visser

Laure CM Herreman

Jennifer Vandooren

Rafaela Vaz Sousa Pereira

Ghislain Opdenakker

...

2024/2/21

SIRPalpha-41BBL FUSION PROTEIN AND METHODS OF USE THEREOF

2024/2/13

VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses

Experimental Hematology & Oncology

Yusheng Lin

Ghizlane Choukrani

Lena Dubbel

Lena Rockstein

Jimena Alvarez Freile

...

2024/3/29

Design of Vaterite Nanoparticles for Controlled Delivery of Active Immunotherapeutic Proteins

Particle & Particle Systems Characterization

Levi Collin Nelemans

Ghizlane Choukrani

Natasha Ustyanovska‐Avtenyuk

Valerie R Wiersma

Lars Dähne

...

2024/3/12

A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for in vitro screening of immunomodulatory checkpoints and …

Frontiers in Immunology

Jimena Álvarez Freile

Yuzhu Qi

Lisa Jacob

Maria Franceskin Lobo

Harm Jan Lourens

...

2023/7/25

Basics of advanced therapy medicinal product development in academic pharma and the role of a GMP simulation unit

I Johanna

A Daudeij

F Devina

C Nijenhuis

B Nuijen

...

2023/12/1

Notch1 promotes resistance to cisplatin by up-regulating Ecto-5′-nucleotidase (CD73) in triple-negative breast cancer cells

Cell Death Discovery

Yuzhu Qi

Meifang Li

Shaozhong Li

De Zeng

Yingsheng Xiao

...

2023/6/30

Pd1-cd70 fusion protein and methods of use thereof

2023/7/13

Salivary extracellular microRNAs for early detection and prognostication of esophageal cancer: a clinical study

Gastroenterology

Kai Li

Yusheng Lin

Yu Zhou

Xiao Xiong

Lu Wang

...

2023/10/1

Advances in Therapeutic Targeting of the Tumor Necrosis Factor Receptor Superfamily Members for Cancer Immunotherapy

Martijn Vlaming

Yuan He

Edwin Bremer

2023/7/7

EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells

Frontiers in Immunology

Vinicio Melo

Levi Collin Nelemans

Martijn Vlaming

Harm Jan Lourens

Valerie R Wiersma

...

2023/7/20

Signal regulatory protein beta 2 is a novel positive regulator of innate anticancer immunity

Frontiers in Immunology

Nienke Visser

Levi Collin Nelemans

Yuan He

Harm Jan Lourens

Macarena González Corrales

...

2023/12/5

The DNA damage response pathway regulates the expression of the immune checkpoint CD47

Communications biology

Lucy Ghantous

Yael Volman

Ruth Hefez

Ori Wald

Esther Stern

...

2023/3/7

Pd1-41bbl-fusionsprotein og fremgangsmåder til anvendelse deraf

2023/9/4

Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance

Valerie Wiersma

Ghizlane Choukrani

Nienke Visser

Natasha Ustyanovska Avtenyuk

Mirjam Olthuis

...

2023/2/2

CD24 is a potential immunotherapeutic target for mantle cell lymphoma

Biomedicines

Jimena Álvarez Freile

Natasha Ustyanovska Avtenyuk

Macarena González Corrales

Harm Jan Lourens

Gerwin Huls

...

2022/5/19

See List of Professors in Edwin Bremer, prof. dr. University(Rijksuniversiteit Groningen)